NCT00791154 2024-08-23
SCLC
NantCell, Inc.
Phase 1/2 Terminated
NantCell, Inc.
Duke University
UNC Lineberger Comprehensive Cancer Center
Abramson Cancer Center at Penn Medicine
Fox Chase Cancer Center
M.D. Anderson Cancer Center
Rochester General Hospital